Inside informationEnglish
Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 25/03/2025, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 115796_20250325